Although analysis of multiple bulk RNA-seq datasets of glioma patients showed that higher mRNA expression of HDAC4 was significantly correlated with lower tumor grade and prolonged OS (60), overexpression of HDAC4 (especially its nuclear overexpression) promotes proliferation, invasion, and drug resistance in glioma cells in cellular experiments (61, 62). Here, HDAC4 is linked to central nervous system cancer.